Success Metrics

Clinical Success Rate

100.0%

Based on 9 completed trials

Completion Rate

100%(9/9)

Active Trials

0(0%)

Results Posted

89%(8 trials)

Phase Distribution

Ph phase_1

11%

Ph not_applicable

89%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

N/ANon-phased studies

8(88.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(9)

Detailed Status

Completed9

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (11.1%)

N/A8 (88.9%)

Trials by Status

completed9100%

Recent Activity

0 active trials

Showing 5 of 9

completednot_applicable

Clinical Trials (9)

Showing 9 of 9 trials

NCT00912028Not Applicable

Clinical Performance Comparison of Several Different Contact Lenses

Completed

NCT00808340Not Applicable

Comparison of Three Soft Bifocal Contact Lenses

Completed

NCT01437319Phase 1

Mucin Balls and Corneal Inflammation Events

Completed

NCT00762788Not Applicable

Clinical Trial of Several Contact Lenses in Extended Wear

Completed

NCT00724945Not Applicable

Comparison of Two Soft Bifocal Contact Lenses

Completed

NCT00584831Not Applicable

Effect of Eye Movement on Toric Lens Orientation and Visual Acuity

Completed

NCT00700752Not Applicable

A Comparison of Two Contact Lenses

Completed

NCT01100424Not Applicable

Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining

Completed

NCT01010555Not Applicable

In-vivo Wettability Grading and Assessment Study

Completed

All 9 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 9